NCT05657743 - A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 16, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Pancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma

Interventions

DEVICE

Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

An intratumoral insertion of radioactive sources \[Ra-224 containing stainless-steel 316LVM tubes- (Alpha DaRT seeds)\]. The seeds release by recoil into the tumor short-lived alpha-emitting atoms

Trial Locations (2)

Unknown

NOT_YET_RECRUITING

Wolfson Medical Center, Holon

RECRUITING

Hadassah Ein Kerem, Jerusalem